Fenfluramine (Fintepla) — Research Compounds Library | RetatrutideCompare
Serotonin releaser; withdrawn from anti-obesity use in 1997 due to valvulopathy. Re-approved in 2020 as Fintepla for Dravet syndrome seizures with REMS monitoring.
Serotonin releaser; withdrawn from anti-obesity use in 1997 due to valvulopathy. Re-approved in 2020 as Fintepla for Dravet syndrome seizures with REMS monitoring.